£2.6M
The pre-seed round was co-led by IQ Capital and Ahren Innovation Capital to support team expansion and technology validation.
O
OxDX
OxDX develops AI powered rapid diagnostic technology for infectious diseases.
Oxford, UK—Founded 2022
£2.6MTotal raised
OxDX is a University of Oxford spin out developing rapid pathogen testing technology that combines super resolution microscopy and machine learning. The platform aims to identify viruses, bacteria and other infectious agents within seconds.
Filed accounts
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from OxDX's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
AB
Alex Batchelor
Chief Executive Officer